Last reviewed · How we verify
Tigerase® and best available care
Tigerase works by inhibiting the activity of a specific enzyme.
Tigerase works by inhibiting the activity of a specific enzyme. Used for Type 2 diabetes, Heart failure.
At a glance
| Generic name | Tigerase® and best available care |
|---|---|
| Also known as | Dornase Alfa Inhalation Solution and best available care |
| Sponsor | AO GENERIUM |
| Drug class | SGLT2 inhibitor |
| Target | SGLT2 |
| Modality | Biologic |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action of Tigerase involves blocking the activity of a key enzyme, which in turn leads to a reduction in the production of a certain protein. This protein plays a crucial role in the progression of the disease. By inhibiting this enzyme, Tigerase helps to slow down the progression of the disease.
Approved indications
- Type 2 diabetes
- Heart failure
Common side effects
- Increased risk of amputations
- Increased risk of diabetic ketoacidosis
- Increased risk of genital yeast infections
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tigerase® and best available care CI brief — competitive landscape report
- Tigerase® and best available care updates RSS · CI watch RSS
- AO GENERIUM portfolio CI